Injectable Drugs Market: By Product (Freeze dried products and Injectable sterile products), By Packaging (Ampules, Vials, Cartridges, and Bottles), By Device Type (Conventional injectable, Prefilled syringes, Auto-injectors, Pen injectors and Variable injectors), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
Injectable Drugs Market: By Product (Freeze dried products and Injectable sterile products), By Packaging (Ampules, Vials, Cartridges, and Bottles), By Device Type (Conventional injectable, Prefilled syringes, Auto-injectors, Pen injectors and Variable injectors), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
PRODUCT OVERVIEW
Initially, pharmaceuticals were only available in the shape of tablets, pills, or capsules, but today's drugs are administered via a more technologically advanced and intelligent system. These systems are designed to deliver medications to specific target sites which would otherwise be hard to reach through the circulatory system. Patients who require medications on a daily basis prefer modern procedures to traditional injection devices. As a result, the growing need for efficient and convenient injectable drug delivery systems presents a profitable potential for manufacturers to build complex, user-friendly, and efficacious devices.
MARKET HIGHLIGHTS
Global Injectable Drugs market is expected to project a notable CAGR of 12.4% in 2031.
Global Injectable Drugs to surpass USD 2,008.7 billion by 2031 from USD 621.7 billion in 2021 at a CAGR of 12.4% in the coming years, i.e., 2021-31. The growing usage of biologics, the increase in the incidence of chronic diseases, the rise in the occurrence of needle sticks, as well as the benefits of injection are all contributing to the market's growth (convenience, easy to use, & reduced pain). Safety syringes, prefilled syringe, and auto injectors have all seen a rise in demand as a result of these issues.
GLOBAL INJECTABLE DRUGS MARKET: SEGMENTS
Conventional injectable segment to grow with the highest CAGR during 2021-31
The global market is divided into five sectors based on device type: conventional injectable, prefilled syringes, auto-injectors, pen injectors, and variable injectors. The Conventional injectable segment led the global market, leading to higher purchases of traditional syringes as a result of increased hospitalization, rising prevalence of common infectious diseases that necessitates hospitalization, and increasing number of operations worldwide. Stopping the growing number of immunization campaigns around the world will also help this segment thrive.
Injectable sterile products segment to grow with the highest CAGR during 2021-31
Based on product type, the market is segmented into freeze dried products and injectable sterile products. With its quality assurance & storability, the injectable sterile product category is the market leader. During surgeries and the treatment of difficult disorders, surgeons choose sterile products in hospitals and clinics. Injectable are sterile and pathogen-free, posing a lesser risk of infection, further extending the market for this segment.
MARKET DYNAMICS
Drivers
Increasing Patient demand, reusable syringes & devices
Consistent R&D to launch breakthrough products
Restraint
Devices and active therapy have a high cost
GLOBAL INJECTABLE DRUGS:
Key Players
Injectable Drugs Market Segments:
PRODUCT OVERVIEW
Initially, pharmaceuticals were only available in the shape of tablets, pills, or capsules, but today's drugs are administered via a more technologically advanced and intelligent system. These systems are designed to deliver medications to specific target sites which would otherwise be hard to reach through the circulatory system. Patients who require medications on a daily basis prefer modern procedures to traditional injection devices. As a result, the growing need for efficient and convenient injectable drug delivery systems presents a profitable potential for manufacturers to build complex, user-friendly, and efficacious devices.
MARKET HIGHLIGHTS
Global Injectable Drugs market is expected to project a notable CAGR of 12.4% in 2031.
Global Injectable Drugs to surpass USD 2,008.7 billion by 2031 from USD 621.7 billion in 2021 at a CAGR of 12.4% in the coming years, i.e., 2021-31. The growing usage of biologics, the increase in the incidence of chronic diseases, the rise in the occurrence of needle sticks, as well as the benefits of injection are all contributing to the market's growth (convenience, easy to use, & reduced pain). Safety syringes, prefilled syringe, and auto injectors have all seen a rise in demand as a result of these issues.
GLOBAL INJECTABLE DRUGS MARKET: SEGMENTS
Conventional injectable segment to grow with the highest CAGR during 2021-31
The global market is divided into five sectors based on device type: conventional injectable, prefilled syringes, auto-injectors, pen injectors, and variable injectors. The Conventional injectable segment led the global market, leading to higher purchases of traditional syringes as a result of increased hospitalization, rising prevalence of common infectious diseases that necessitates hospitalization, and increasing number of operations worldwide. Stopping the growing number of immunization campaigns around the world will also help this segment thrive.
Injectable sterile products segment to grow with the highest CAGR during 2021-31
Based on product type, the market is segmented into freeze dried products and injectable sterile products. With its quality assurance & storability, the injectable sterile product category is the market leader. During surgeries and the treatment of difficult disorders, surgeons choose sterile products in hospitals and clinics. Injectable are sterile and pathogen-free, posing a lesser risk of infection, further extending the market for this segment.
MARKET DYNAMICS
Drivers
Increasing Patient demand, reusable syringes & devices
Consistent R&D to launch breakthrough products
Restraint
Devices and active therapy have a high cost
GLOBAL INJECTABLE DRUGS:
Key Players
- Becton
- Baxter International Inc.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc.
- AstraZeneca
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Novartis AG
- Dickinson and Company
- Novo Nordisk A/S
Injectable Drugs Market Segments:
- By Product
- Freeze dried products
- Injectable sterile products
- By Packaging
- Ampules
- Vials
- Cartridges
- Bottles
- By Device Type
- Conventional injectable
- Prefilled syringes
- Auto-injectors
- Pen injectors
- Variable injectors
- Injectable Drugs Market Dynamics
- Injectable Drugs Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Executive Summary
2 GLOBAL INJECTABLE DRUGS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL INJECTABLE DRUGS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL INJECTABLE DRUGS MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL INJECTABLE DRUGS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Freeze dried products, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Injectable sterile products, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Packaging: Market Share (2020-2031F)
12.3.1. Ampules, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vials, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Cartridges, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Bottles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By Device Type: Market Share (2020-2031F)
12.4.1. Conventional injectable, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Prefilled syringes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Auto-injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Pen injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Variable injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Baxter International Inc.
13.3. Sanofi
13.4. Pfizer Inc.
13.5. GlaxoSmithKline plc.
13.6. AstraZeneca
13.7. GILEAD SCIENCES, INC.
13.8. Merck & Co., Inc.
13.9. Novartis AG
13.10. Novo Nordisk A/S
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2 GLOBAL INJECTABLE DRUGS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL INJECTABLE DRUGS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL INJECTABLE DRUGS MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL INJECTABLE DRUGS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Freeze dried products, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Injectable sterile products, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Packaging: Market Share (2020-2031F)
12.3.1. Ampules, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vials, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Cartridges, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Bottles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By Device Type: Market Share (2020-2031F)
12.4.1. Conventional injectable, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Prefilled syringes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Auto-injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Pen injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Variable injectors, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Baxter International Inc.
13.3. Sanofi
13.4. Pfizer Inc.
13.5. GlaxoSmithKline plc.
13.6. AstraZeneca
13.7. GILEAD SCIENCES, INC.
13.8. Merck & Co., Inc.
13.9. Novartis AG
13.10. Novo Nordisk A/S
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
